Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Arch Neurol. 2009 Aug;66(8):964–966. doi: 10.1001/archneurol.2009.152

Figure 1.

Figure 1

NMO-IgG titers by clinical diagnosis at attack onset. NMO-IgG was detected exclusively in NMO spectrum disorders and was notably absent in any patient with monophasic ON, short TM, ADEM, or MS.

M=monophasic; R=recurrent